should i take glp-1 who The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 What Should I Expect During

The dual agonist mechanism distinguishes tirzepatide from earlier GLP-1 receptor agonists such as semaglutide or dulaglutide

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1

Published randomized trials have examined chromium picolinate's effects on fasting insulin, glucose response, and carbohydrate-specific craving in specific study populations

Adv Ther 28(3):213226 Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Notably, despite seeing a 41% single-day surge in early March, HIMS remains down nearly 10% in 2026

Programs that address only weight will be evaluated against programs that address weight and its downstream burden